Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 36% ± 16% | |
astrocyte | 11 studies | 27% ± 11% | |
platelet | 8 studies | 32% ± 12% | |
endothelial cell | 7 studies | 27% ± 9% | |
capillary endothelial cell | 5 studies | 19% ± 4% | |
fibroblast | 5 studies | 21% ± 6% | |
adipocyte | 4 studies | 22% ± 3% | |
oligodendrocyte precursor cell | 4 studies | 35% ± 11% | |
glutamatergic neuron | 3 studies | 18% ± 3% | |
ependymal cell | 3 studies | 28% ± 15% | |
megakaryocyte | 3 studies | 32% ± 18% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% | |
type I pneumocyte | 3 studies | 17% ± 0% | |
hepatocyte | 3 studies | 40% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 3726.08 | 2566 / 2642 | 100% | 38.52 | 703 / 705 |
thymus | 100% | 5351.49 | 650 / 653 | 96% | 21.58 | 581 / 605 |
adrenal gland | 94% | 4178.25 | 242 / 258 | 97% | 33.51 | 224 / 230 |
liver | 94% | 4639.38 | 213 / 226 | 95% | 30.73 | 387 / 406 |
skin | 91% | 3056.29 | 1654 / 1809 | 96% | 19.38 | 451 / 472 |
prostate | 97% | 3771.96 | 238 / 245 | 86% | 11.25 | 431 / 502 |
kidney | 89% | 1838.43 | 79 / 89 | 93% | 20.26 | 841 / 901 |
ovary | 99% | 5076.04 | 178 / 180 | 83% | 11.13 | 355 / 430 |
breast | 99% | 4876.74 | 456 / 459 | 69% | 13.51 | 772 / 1118 |
lung | 99% | 5171.48 | 574 / 578 | 63% | 13.58 | 725 / 1155 |
intestine | 98% | 5364.92 | 951 / 966 | 57% | 5.85 | 299 / 527 |
uterus | 97% | 4472.49 | 165 / 170 | 45% | 5.21 | 208 / 459 |
stomach | 83% | 2464.85 | 298 / 359 | 59% | 6.52 | 168 / 286 |
esophagus | 85% | 2689.69 | 1224 / 1445 | 48% | 4.12 | 88 / 183 |
bladder | 90% | 3198.43 | 19 / 21 | 35% | 4.40 | 177 / 504 |
pancreas | 26% | 302.59 | 86 / 328 | 87% | 11.88 | 154 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 33.10 | 80 / 80 |
blood vessel | 99% | 4990.78 | 1316 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 4925.36 | 1184 / 1204 | 0% | 0 | 0 / 0 |
heart | 89% | 2254.25 | 769 / 861 | 0% | 0 | 0 / 0 |
spleen | 88% | 1550.63 | 212 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 1397.65 | 632 / 929 | 0% | 0 | 0 / 0 |
muscle | 44% | 545.16 | 354 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 2.43 | 14 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016126 | Biological process | sterol biosynthetic process |
GO_0045654 | Biological process | positive regulation of megakaryocyte differentiation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005506 | Molecular function | iron ion binding |
GO_0000254 | Molecular function | C-4 methylsterol oxidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FAXDC2 |
Protein name | Fatty acid hydroxylase domain containing 2 Fatty acid hydroxylase domain-containing protein 2 |
Synonyms | C5orf4 |
Description | FUNCTION: Promotes megakaryocyte differentiation by enhancing ERK phosphorylation and up-regulating RUNX1 expression. . |
Accessions | ENST00000520968.5 E5RK16 ENST00000522825.1 E5RH84 ENST00000521518.5 ENST00000326080.10 [Q96IV6-1] ENST00000520461.1 ENST00000524363.5 E5RK01 Q96IV6 ENST00000517938.5 [Q96IV6-2] ENST00000518651.5 ENST00000519501.5 E5RFJ7 E5RJN8 E5RJQ9 E5RIK6 E5RH66 ENST00000520581.5 |